Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Scavelli

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Future Oncology (London, England)|December 5, 2014
Long-term efficacy and safety of a third-line treatment with eribulin plus trastuzumab in a young breast cancer patientClaudio Scavelli, Federica Gallù
Recenti Progressi in Medicina|December 20, 2002
[Chemokines and tumors]Antonio Pellegrino, Angelo Vacca, Claudio Scavelli, et al.
Stem Cells and Development|December 14, 2004
Hematopoietic cancer and angiogenesisDomenico Ribatti, Claudio Scavelli, Aldo M Roccaro, et al.
Journal of Anatomy|June 17, 2004
Lymphatics at the crossroads of angiogenesis and lymphangiogenesisClaudio Scavelli, Elisabetta Weber, Margherita Aglianò, et al.
Medical Oncology (Northwood, London, England)|April 25, 2013
Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?Nicola Calvani, Franco Morelli, Vincenzo Chiuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2005
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myelomaAngelo Vacca, Claudio Scavelli, Vittorio Montefusco, et al.
Blood|May 11, 2006
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myelomaAngelo Vacca, Claudio Scavelli, Guido Serini, et al.
Molecular Cancer Therapeutics|December 20, 2007
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myelomaClaudio Scavelli, Giulia Di Pietro, Teresa Cirulli, et al.
Blood|July 12, 2003
Endothelial cells in the bone marrow of patients with multiple myelomaAngelo Vacca, Roberto Ria, Fabrizio Semeraro, et al.
Tumori|December 19, 2019
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experienceEufemia S Lutrino, Laura Orlando, Antonio Febbraro, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|December 5, 2014
Long-term efficacy and safety of a third-line treatment with eribulin plus trastuzumab in a young breast cancer patientClaudio Scavelli, Federica Gallù
Recenti Progressi in Medicina|December 20, 2002
[Chemokines and tumors]Antonio Pellegrino, Angelo Vacca, Claudio Scavelli, et al.
Stem Cells and Development|December 14, 2004
Hematopoietic cancer and angiogenesisDomenico Ribatti, Claudio Scavelli, Aldo M Roccaro, et al.
Journal of Anatomy|June 17, 2004
Lymphatics at the crossroads of angiogenesis and lymphangiogenesisClaudio Scavelli, Elisabetta Weber, Margherita Aglianò, et al.
Medical Oncology (Northwood, London, England)|April 25, 2013
Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?Nicola Calvani, Franco Morelli, Vincenzo Chiuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2005
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myelomaAngelo Vacca, Claudio Scavelli, Vittorio Montefusco, et al.
Blood|May 11, 2006
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myelomaAngelo Vacca, Claudio Scavelli, Guido Serini, et al.
Molecular Cancer Therapeutics|December 20, 2007
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myelomaClaudio Scavelli, Giulia Di Pietro, Teresa Cirulli, et al.
Blood|July 12, 2003
Endothelial cells in the bone marrow of patients with multiple myelomaAngelo Vacca, Roberto Ria, Fabrizio Semeraro, et al.
Tumori|December 19, 2019
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experienceEufemia S Lutrino, Laura Orlando, Antonio Febbraro, et al.
Pageof 2